|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.3800 AUD | -1.30% |
|
-1.30% | -41.54% |
| Market Cap | 114M 79.46M 69.44M 64.08M 59.07M 111M 7.65B 766M 301M 3.75B 298M 292M 12.9B | P/E 2026 * |
-6.33x | P/E 2027 * | -2.38x |
|---|---|---|---|---|---|
| Enterprise Value | 122M 85.1M 74.37M 68.62M 63.25M 119M 8.2B 820M 323M 4.01B 320M 313M 13.82B | EV / Sales 2026 * |
12.8x | EV / Sales 2027 * | 20.6x |
| Free-Float |
60.61% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | -1.30% | ||
| 1 week | -1.30% | ||
| Current month | -6.17% | ||
| 1 month | -25.49% | ||
| 3 months | -33.33% | ||
| 6 months | -45.71% | ||
| Current year | -41.54% |
| 1 week | 0.36 |  | 0.39 |
| 1 month | 0.36 | | 0.5 |
| Current year | 0.36 | | 0.73 |
| 1 year | 0.34 | | 0.73 |
| 3 years | 0.28 | | 0.78 |
| 5 years | 0.28 | | 1.38 |
| 10 years | 0.13 | | 1.88 |
| Manager | Title | Age | Since |
|---|---|---|---|
James Graham
CEO | Chief Executive Officer | - | 28/08/2020 |
Justin Reynolds
DFI | Director of Finance/CFO | - | - |
Michele Dilizia
CTO | Chief Tech/Sci/R&D Officer | - | 30/09/2020 |
| Director | Title | Age | Since |
|---|---|---|---|
Michele Dilizia
BRD | Director/Board Member | - | 01/10/2012 |
James Graham
BRD | Director/Board Member | - | 01/05/2012 |
| Director/Board Member | - | 01/09/2022 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 24/02/26 | Expiration | Chief Executive Officer | 2,250,000 | 0.7781% | ||
| 14/10/25 | Expiration | Chief Executive Officer | 745,962 | 0.3217% | ||
| 21/11/24 | Buy | Chief Technology Officer | 1,600,000 | 0.6900% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.30% | -1.30% | +8.57% | -40.62% | 79.46M | |
| +0.85% | -0.80% | +54.84% | +163.70% | 1,051B | |
| +1.23% | -1.53% | +55.26% | +59.07% | 609B | |
| +0.04% | +2.58% | +32.96% | +88.75% | 450B | |
| +0.78% | -0.71% | +30.04% | +24.61% | 330B | |
| +1.41% | +0.58% | +33.92% | +47.20% | 284B | |
| -0.27% | -1.87% | +22.13% | +23.47% | 263B | |
| -1.76% | +2.37% | -22.19% | -38.45% | 223B | |
| -1.42% | +0.80% | +22.81% | +60.77% | 198B | |
| -1.48% | +3.43% | +23.42% | +73.31% | 167B | |
| Average | -0.24% | +0.36% | +26.18% | +46.18% | 357.51B | |
| Weighted average by Cap. | +0.22% | +0.02% | +37.75% | +81.49% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 9.56M 6.67M 5.83M 5.38M 4.96M 9.35M 643M 64.33M 25.3M 315M 25.06M 24.51M 1.08B | 8.19M 5.72M 5M 4.61M 4.25M 8.01M 551M 55.13M 21.68M 270M 21.48M 21.01M 929M |
| Net income | -18.68M -13.05M -11.4M -10.52M -9.7M -18.28M -1.26B -126M -49.46M -615M -49M -47.92M -2.12B | -47.2M -32.96M -28.8M -26.58M -24.5M -46.17M -3.17B -318M -125M -1.55B -124M -121M -5.35B |
| Net Debt | 8.07M 5.64M 4.92M 4.54M 4.19M 7.89M 543M 54.31M 21.36M 266M 21.16M 20.7M 915M | 54.63M 38.14M 33.33M 30.76M 28.35M 53.44M 3.67B 368M 145M 1.8B 143M 140M 6.19B |
Employees
-
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 17/07/26 | A$0.3800 | -1.30% | 155,988 |
| 16/07/26 | A$0.3850 | +5.48% | 195,033 |
| 15/07/26 | A$0.3650 | -5.19% | 150,075 |
| 14/07/26 | A$0.3850 | -1.28% | 406,483 |
| 13/07/26 | A$0.3900 | +1.30% | 354,511 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- RCE Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
